Research Use Only · COA Available · Authorized Researchers
Back to All Products

peptide-solutions

MOTS-C

Mitochondrial peptide for metabolic research (40 mg per vial)

Research Compound

Manufactured under strict quality control protocols with full analytical testing. Certificate of Analysis (COA) available upon request.

Purity: >98%Form: LyophilizedStorage: -20°CGrade: Research
MOTS-C

MOTS-c is a mitochondria-derived peptide encoded in the mitochondrial genome. Research demonstrates its role in metabolic regulation, insulin sensitivity, and stress response.

Compound Specifications

Purity Level>98%
Physical FormLyophilized powder (40mg/vial)
Molecular Weight2174.5 g/mol
CAS Number1627580-64-6
IUPAC NameL-methionyl-L-arginyl-L-tryptophyl-L-glutaminyl-L-alpha-glutamyl-L-methionyl-glycyl-L-tyrosyl-L-isoleucyl-L-phenylalanyl-L-tyrosyl-L-prolyl-L-arginyl-L-lysyl-L-leucyl-L-arginine

Select the amount contained in each vial.

Choose one vial, or choose a kit with 10 units priced as 8.

$70USD

Amount per vial: 40mg

1
Research-Grade
COA Available
Tracked Shipping
Third-Party Tested

Scientific Documentation

Research Reference

Detailed research information, pharmacological profile, and handling specifications

Mechanism of Action

MOTS-c acts as a mitochondrial-encoded metabolic regulator that coordinates the "retrograde" communication between the mitochondria and the nuclear genome. Its primary mechanism involves a dual-track response that optimizes cellular energy states and enhances stress resilience. • Folate Cycle Inhibition & AMPK Activation: The hallmark of MOTS-c activity is its interaction with the folate-methionine cycle. By inhibiting the 10-formyl-tetrahydrofolate dehydrogenase (FDH) or related enzymes, the peptide triggers a transient accumulation of 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR). This endogenous AMP-mimetic binds to and activates AMPK, which subsequently upregulates glucose uptake via GLUT4 translocation and stimulates fatty acid β-oxidation. • Nuclear Retrograde Signaling: Under conditions of metabolic stress, MOTS-c translocates from the mitochondria to the nucleus. Once inside, it interacts with transcription factors such as ATF1 and NRF2. This binding facilitates the expression of an "aerobic gene program," promoting the transcription of antioxidant response elements (AREs) and genes involved in mitochondrial protein import. • Insulin Sensitization: The peptide reduces systemic insulin resistance by decreasing the accumulation of intramyocellular lipids. By promoting a shift toward lipid catabolism, MOTS-c prevents the lipotoxicity that typically impairs the insulin signaling cascade (IRS-1/PI3K/Akt pathway) in skeletal muscle. • Mitochondrial Homeostasis: MOTS-c supports organelle-level quality control by enhancing the expression of nuclear-encoded mitochondrial genes. This ensures that the mitochondrial pool remains functional and efficient, particularly during aging or high-fat-diet challenges, by preventing the decline of mitochondrial membrane potential and respiratory capacity.

Verified Buyer Reviews

What researchers say

Loading reviews...

Research Use Only Disclaimer

This product is intended strictly for laboratory and research purposes only. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. By purchasing, you confirm that you are an authorized researcher or institution and that this product will be used solely for legitimate research purposes in compliance with all applicable laws and regulations.

Related Compounds

Other research peptides you may be interested in